<DOC>
	<DOCNO>NCT01329744</DOCNO>
	<brief_summary>This study examine effect recombinant insulin like growth factor - I body composition , glucose homeostasis , lipid , adult HIV infection sign metabolic disease .</brief_summary>
	<brief_title>Effects IGF-I HIV Metabolic Disease</brief_title>
	<detailed_description>The main objective study follow : 1 . Determine effect recombinant human insulin like growth factor-I ( rhIGF-I ) ( generic : mecasermin ) subcutaneous adiposity patient HIV lipodystrophy syndrome . 2 . Determine effect rhIGF-I glucose homeostasis lipid patient HIV lipodystrophy . 3 . Determine effect rhIGF-I apoptosis , mitochondrion , inflammation , adipose tissue obtain patient HIV lipodystrophy .</detailed_description>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>HIV positive undetectable viral load No change antiretrovirals 3 month Evidence lipoatrophy limb , face gluteal area Dyslipidemia define : Fasting triglyceride &gt; 200 OR HDL cholesterol &lt; 40 mg/dL Abnormal glucose homeostasis define : Fasting hyperinsulinemia &gt; 20 uU/mL OR Fasting glucose 100125 mg/dL , inclusive Two consecutive viral &gt; 75 &gt; 50 copies/mL use test list Presence AIDS waste Change antiretroviral medication ( dose ) prior 3 month Coronary artery disease , cerebrovascular , peripheral arterial disease Diabetes mellitus Adrenal insufficiency , hypoglycemia , thyroid disease , endocrine disorder untreated Malignancy Eating disorder Pregnancy ( urine pregnancy test require female ) Previous liposuction bariatric surgery Other systemic condition disorder discretion investigator Current use systemic glucocorticoid , agent affect body weight glucose homeostasis drug discretion investigator Use interferon within past six month Use insulin , insulin secretagogue , thiazolidinedione , metformin prior 3 month Initiation dose adjustment , within prior 3 month , follow drug drug class : fibrate , cholesterol bind resin , statin , niacin , omega 3 fatty acid ( fish oil ) . Use uridine , growth hormone , IGFI , growth hormone release factor analogue</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HIV lipodystrophy</keyword>
</DOC>